The following Appendix 4D and Half-Year Report has been lodged with ASX.
Read Appendix 4D and Half-Year Report.
Imagion Biosystems receives AU$3.5 million in R&D tax incentives
MELBOURNE — Imagion Biosystems Limited (ASX: IBX), a company dedicated to improving healthcare through the earlier detection of cancer, is pleased to report that it